Market influx of Plavix generic drugs.

Plavix (clopidogrel), an anti-thrombosis drug and a Sanofi-Synthelabo's top blockbuster, ended in its review term as of July 6, implying that its generic product influx into the markets would stage a fierce battle.

As the first clopidogrel generic drug, Chongkundang obtained a conditional approval with the bio-equivalency test by the KFDA on March 23, other companies including Dong-A fol...